Total
0
Shares
Source: Alpha Cognition.
Market Herald logo

Find out more about this capital raise

Be the first with the news that moves the market
  • Alpha Cognition (ACOG) has announced a C$12.5 million public offering led by Raymond James
  • The company intends to use the proceeds to develop and market its flagship formulations against Alzheimer’s and ALS
  • The offering is expected to close on or about September 29, 2021
  • Alpha Cognition is a clinical-stage biopharmaceutical company developing treatments for underserved neurodegenerative diseases
  • Alpha Cognition (ACOG) closed down by 11.39 per cent trading at $1.40 per share

Alpha Cognition (ACOG) has announced a C$12.5 million public offering led by Raymond James.

The company will offer 8,350,000 units priced at $1.50 per unit.

Each unit consists of one Alpha common share and one common share purchase warrant.

Each warrant entitles the holder to acquire one common share for $1.75 for 24 months from the closing of the offering.

The company intends to use the proceeds for working capital, general corporate purposes and for the marketing and clinical development of its flagship formulations:

  • Alpha-1062, which is intended as a treatment for Alzheimer’s Disease
  • Alpha-0602, which is intended as a treatment for ALS

The offering is pursuant to Alpha’s Canadian base-shelf prospectus dated August 25, 2021. The company will file a prospectus supplement in each province and territory except Quebec.

The offering is expected to close on or about September 29, 2021.

Alpha Cognition is a clinical-stage biopharmaceutical company developing treatments for underserved neurodegenerative diseases.

Alpha Cognition (ACOG) closed down by 11.39 per cent trading at $1.40 per share.

More From The Market Herald

" Andlauer Healthcare Group (TSX:AND) completes $169M bought deal offering

Andlauer Healthcare Group Inc. (AND) and Andlauer Management Group Inc. completed a bought deal offering of 3.5 million subordinate voting shares (SVSs).

" Avricore (TSXV:AVCR) expands HealthTab to select Shoppers Drug Mart locations in BC

Avricore Health (AVCR) has expanded its patient testing with the HealthTab platform in select Shoppers Drug Mart pharmacies in BC.

" Sego Resources (TSXV:SGZ) announces a non-brokered private placement

Sego Resources (SGZ) has announced a non-brokered private placement for proceeds of up to $405,000.

" Clearmind (CSE:CMND) signs development and supply agreement with Aragen Life Sciences

Clearmind Medicine (CMND) will work with Aragen Life Sciences to produce its innovative molecule, 5-Methoxy-2-aminoindane (MEAI).